Television Francaise(TF1): 1 director

A director at Television Francaise(TF1) bought 30,000 shares at 8.441EUR and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The na...

ODDO : Feedback from 9th ODDO BHF TMT Forum

Our two-day 9th virtual TMT Forum was attended by 32 listed companies and 292 investors. The trends in media seem to point to a correct start to the year. Telecom players are optimistic on the regulatory front (intra-market consolidation). Software & IT services and semis continue to see mixed trends, apart from in AI and some hopes that a few companies will benefit from the rise of defence spending. In terms of companies, the main positive messages came from Auto1, CMCOM, Indra, Infineon, Telecom Italia, and TF1. Negative messages Gamma, AT&S and Siltronic (TP down to €65 vs €75)

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 03/10/2025

ODDO : Tariff risk in the US: what implications for the spirits sector?

The US represents 28% of the global spirits market in value, with the vast majority of products imported. The tariffs announced by Trump therefore particularly affect this industry. We estimate at -6% the impact on EBIT the one-off effect of trade tariffs, to which we must add -1% related to the depreciation of the dollar. Due to the probable impact on the US economy, we have pushed back the timing of the recovery of the spirits market our EPS estimates (EPS cut by 3% on average in 2025 and 2026) We continue to favour quality with our Top Pick Diageo (Outperform) and switch to Neutral on Rémy ...

Teva : On the road to investment grade

Teva successfully delivered the 1st phase of its ‘Pivot To Growth’ strategy with a return to revenue growth in 2023 and 2024 (+3% and +9% on constant FX respectively, excluding a $ 500m payment from Sanofi in Q4 2023). The company will now enter the 2nd phase of its strategy (‘accelerate growth’) with a sustained momentum for its AUSTEDO/AJOVY and a good a pipeline of biosimilar and innovative drugs (Olanzapine LAI in 2026, DARI in 2027). These developments should more than compensate for pricing headwinds in the US, we believe. Operating margins should be constrained by R&D and marketing inve...

ODDO : Risque tarifaire aux USA : quelles implications pour le secteur des spiritueux ?

Les USA représentent 28% du marché mondial des spiritueux en valeur avec une vaste majorité de produits importés. Les tarifs douaniers, annoncés par Trump, concernent donc particulièrement cette industrie. Nous estimons à 6% l’impact sur l’EBIT de l’effet one-off des droits de douane auquel il faut ajouter 1% lié à la baisse du dollar. En raison de l’impact probable sur l’économie américaine, nous décalons le timing de reprise du marché des spiritueux dans nos estimations (BPA abaissés de 3% en moyenne en 2025 et 2026). Nous privilégions la qualité avec notre top pick Diageo (Surperformance) e...